Your web browser does not support JavaScript, but it does not affect browsing through the rest of the web site.

MEDiT 2018 to Help Taiwan Firms Seize New Opportunities in Smart Healthcare

Font size:
Small
Medium
Large

MEDiT 2018 to Help Taiwan Firms Seize New Opportunities in Smart Healthcare

MEDiT 2018 invited industry experts to share their insights on smart healthcare and market trends.
MEDiT 2018 invited industry experts to share their insights on smart healthcare and market trends.

The 2018 Medical Electronics & Device in Taiwan Forum (MEDiT), is being held on October 11 and 12 in Taipei. This year's event centers on the theme "cross-industry synergy and seizing new business opportunities in smart healthcare." Among those invited speakers are Ozgur Baydarol, R&D Manager at Turkish household appliances maker Arçelik A.Ş.; Yoichiro Hamazaki, General Manager of the IT Healthcare Project at Japan's Teijin Ltd.; and Samuel Ding, former Research Director at Baxter Healthcare. These experts shared their insights on smart healthcare and market trends, which would pave the way for greater cross-industry synergy and help firms seize blue ocean opportunities.

 

The Industrial Development Bureau of the Ministry of Economic Affairs pointed out the enormous global market potential of Taiwan-made medical devices. In a bid to boost Taiwan’s visibility in international markets, Taiwan continues to strengthen innovation-oriented R&D in the biomedical industry, while also promoting smart medical devices and systems. It hopes to utilize the advantage of the industrial clusters here to make Taiwan an Asia-Pacific hub for innovative R&D in biotechnology, pharmaceuticals, and medical devices.

 

Dr. Chii-Wann Lin, ITRI's Vice President and General Director of Biomedical Technology and Device Research Laboratories, remarked that ITRI aims to foster an innovation ecosystem and biomedical clusters in response to the government's 5+2 innovative industries plan. He further illustrated ITRI’s efforts in promoting the growth and export of high-end medical devices. For instance, ITRI’s startup Somnics, which developed a device to treat Obstructive Sleep Apnea (OSA), has obtained the permit to sell its product in Malaysia, a successful attempt to tap into the ASEAN market.

 

This year marks the 11th anniversary of MEDiT, with the forum having become the premier international event for Taiwan's medical device industry. Besides introducing the emerging global business models for healthcare and medical devices, our invited speakers will share insights about key markets in Europe and the U.S. Meanwhile, business match-making meetings are arranged for the second day, offering the opportunity for one-on-one talks between domestic manufacturers and international sales channels. These meetings will promote business interaction in a substantive manner, with the hope of assisting Taiwan firms in expanding their presence into international markets and becoming part of the global business value chain.

ITRI's Vice President and General Director of Biomedical Technology and Device Research Laboratories Dr. Chii-Wann Lin (center), and Industry, Science and Technology International Strategy Center Stephen Su (second right) at the forum.
ITRI's Vice President and General Director of Biomedical Technology and Device Research Laboratories Dr. Chii-Wann Lin (center), and Industry, Science and Technology International Strategy Center Stephen Su (second right) at the forum.